Govt to slash MRP of 3 anti-cancer drugs after exemption in customs duty, GST rate cut

by IANS |

New Delhi, Oct 29 (IANS) After custom duty exemption and a reduction in GST rates, the National Pharmaceutical Pricing Authority (NPPA) has now directed the drug manufacturers to reduce the MRP on three anti-cancer medications, the Ministry of Chemicals and Fertilisers said on Tuesday.


The NPPA in an office memorandum dated October 28 directed “the concerned manufacturers to reduce the MRP on three anti-cancer drugs, Trastuzumab, Osimertinib and Durvalumab”.


“This is in line with the Government’s commitment to ensure the availability of drugs at affordable prices,” the ministry added.


In the Union Budget 2024-25, the government exempted customs duty on the three cancer drugs to reduce the financial burden of people suffering from cancer and also to facilitate accessibility. The government also slashed the GST rate from 12 per cent to 5 per cent on these three cancer medicines.


“Accordingly, there should be a reduction in MRP of these drugs in the market, and benefits of reduced taxes and duties should be passed on to the consumers,” the memorandum said.


It further directed the manufacturers “to issue a price list or supplementary price list to the dealers, State Drugs Controllers, and the Government indicating changes and to submit information regarding a price change to NPPA through Form-II/ Form V”.


While Trastuzumab Deruxtecan is used for breast cancer, Osimertinib is for lung cancer; and Durvalumab is for both lung cancer and biliary tract cancer.


Cancer cases are rising significantly in India. According to a Lancet study, India registered about 12 lakh new cancer cases and 9.3 lakh deaths in 2019 -- the second-highest contributor to the disease burden in Asia.


The number climbed to 13.9 lakh in 2020, which further soared to 14.2 lakh and 14.6 lakh in the years 2021 and 2022, respectively, the study showed.

Latest News
WPL 2025: RCB to host camps for player selection ahead of auction, says Rangarajan Sat, Nov 09, 2024, 03:36 PM
Over 7,000 participants took part in Delhi’s 'Run for Inclusion' Sat, Nov 09, 2024, 03:32 PM
Congress govt in Karnataka will not complete its full term: Deve Gowda Sat, Nov 09, 2024, 03:31 PM
Three killed in road accident in Bengal's Malda Sat, Nov 09, 2024, 03:29 PM
Doctor explains why a low-salt diet may not be healthy for everyone Sat, Nov 09, 2024, 03:28 PM
Gram Sabha meetings in TN postponed to Nov 23 Sat, Nov 09, 2024, 02:49 PM
Carrying Constitution & filing FIR against media, aren't you ashamed: Union Minister to Karnataka CM Sat, Nov 09, 2024, 02:43 PM
Meghalaya: NEHU students refuse to call of stir despite Governor's appeal, assurances Sat, Nov 09, 2024, 01:54 PM
Medtech leaders welcome govt's move to launch Rs 500cr scheme for medical devices Sat, Nov 09, 2024, 01:14 PM
I-T Dept raids locations linked to Jharkhand CM's PS, others Sat, Nov 09, 2024, 01:08 PM
Air quality worsens in BiH as cold season begins Sat, Nov 09, 2024, 01:05 PM
RG Kar financial case: CBI gets more clues against Ashish Pandey Sat, Nov 09, 2024, 01:03 PM
Varun Chakaravarthy and Ravi Bishnoi had a great partnership with the ball, says Mark Boucher Sat, Nov 09, 2024, 01:02 PM
Woman dies during treatment; family alleges rape & murder by youth Sat, Nov 09, 2024, 12:27 PM
Sudhanshu Trivedi snubs Pak at UN, says J&K 'will remain integral part of India' Sat, Nov 09, 2024, 12:25 PM